FDA Adverse Event Injury Summary report: N

ECHO B-MTRC MP RP SO 8

MDR report key: 8648403 · Received May 28, 2019

Report

Report Number
0001825034-2019-02338
Event Type
Injury
Date Received
May 28, 2019
Date of Event
April 4, 2019
Report Date
August 19, 2019
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JDI
PMA / PMN Number
K143009
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

UPON REASSESSMENT OF THE REPORTED EVENT, THE STEM WAS DETERMINED TO BE NOT REPORTABLE. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.

Description of Event or Problem · 0

UPON REASSESSMENT OF THE REPORTED EVENT, THE STEM WAS DETERMINED TO BE NOT REPORTABLE. THE INITIAL REPORT WAS FORWARDED IN ERROR AND SHOULD BE VOIDED.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: BIOMET G7 SHELL CAT#010000662 LOT#6395394, BIOMET TAPER SLEEVE CAT#650-1064 LOT#2955104, BIOMET HEAD CAT#650-1057 LOT#2955098, ZIMMER BONE SCREW CAT#00625006530 LOT#64228001, BIOMET LINER CAT#010000817 LOT#6354149. THE DEVICE WILL NOT BE RETURNED FOR ANALYSIS, DUE TO LOCATION OF DEVICE IS UNKNOWN; HOWEVER, AN INVESTIGATION OF THE REPORTED EVENT IS IN PROGRESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2019 - 02337.

Description of Event or Problem · 1

IT WAS REPORTED THE PATIENT UNDERWENT PRIMARY LEFT THA. SUBSEQUENTLY, THE PATIENT UNDERWENT AN I&D PROCEDURE APPROXIMATELY 2 MONTHS POST IMPLANTATION DUE TO INFECTION. IT WAS NOTED THE CERAMIC HEAD, LINER, SCREW AND TAPER WERE REMOVED. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
441210 ECHO B-MTRC MP RP SO 8 PROSTHESIS, HIP JDI ZIMMER BIOMET, INC. N/A 668350

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R